Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03463187 · ClinicalTrials.gov registry record · Phase 1
Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis
A Phase 1 study, sponsored by Jiangsu HengRui Medicine Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 211
- Enrollment target
NCT03463187: Completed Phase 1 study, sponsored by Jiangsu HengRui Medicine Co..
NCT03463187 is a Phase 1 study that has completed, run by Jiangsu HengRui Medicine Co.. The registered enrollment target is 211 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (252% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03463187, a Phase 1 study, has completed, sponsored by Jiangsu HengRui Medicine Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 211 participants
- Enrollment target
Study Summary
This is a multi-regional, randomized, double-blind, placebo-controlled, clinical trial to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of SHR-1314 in adults with moderate-to-severe plaque psoriasis.
Primary Outcome
Clinically significant events were defined as abnormal laboratory values and/or adverse events that are related to treatment
Interventions
- DRUG Placebo
- BIOLOGICAL SHR-1314
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2017-12-15 |
| Est. Completion | 2020-08-31 |
| Phase | Phase 1 |
What the finished NCT03463187 record still lists
NCT03463187 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (252% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03463187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03463187 about?
NCT03463187 is a clinical study titled "Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis". This is a multi-regional, randomized, double-blind, placebo-controlled, clinical trial to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of SHR-1314 in adults with moderate-to-severe plaque psoriasis.
What is the current status of trial NCT03463187?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 211 participants. The study started on 2017-12-15. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03463187?
The interventions under investigation include: Placebo (DRUG), SHR-1314 (BIOLOGICAL).
Who is sponsoring clinical trial NCT03463187?
This trial is sponsored by Jiangsu HengRui Medicine Co., which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03463187's enrollment target sits among peer trials
211 245th of 2000 higher than 1,756 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI